S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

OLMA Olema Pharmaceuticals Inc

8.78

0.00 (0.00%)

Pre Market

Last Updated: 20:06:13

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Olema Pharmaceuticals Charts.

Olema Pharmaceuticals (NASDAQ:OLMA)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Olema Pharmaceuticals Charts.

Olema Pharmaceuticals Inc News

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Monday 25 November 2024 (9 hours ago) • PR Newswire (US)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Wednesday 13 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Olema Oncology to Participate in Upcoming Investor Conferences
Wednesday 6 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 5 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024
Wednesday 23 October 2024 (1 month ago) • GlobeNewswire Inc.

Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Wednesday 9 October 2024 (2 months ago) • GlobeNewswire Inc.

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 3 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 27 September 2024 (2 months ago) • Edgar (US Regulatory)

More Olema Pharmaceuticals Inc News Articles

SG Issuer Sg Issuer Mc M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions